CClinicalTrials.gg
RecruitingNCT06933407SE-inc1Updated Apr 18, 2025

Elastographic Assessment of Suburethral Tissue in Continent and Incontinent Women

An observational study in Urinary Incontinence, Urinary Incontinence, Stress and Urinary Incontinence (UI), sponsored by Szeged University. Recruiting at 1 site in Hungary. Open to female participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-18.

Sponsored by Szeged University · Observational

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years to 99 Years
Sex
Female
01

Study summary

Strain elastography (SE) will be utilized as a non-invasive imaging technique to evaluate tissue elasticity and biomechanical properties in women with stress urinary incontinence (SUI) and in continent controls. The primary aim is to determine whether SE can detect differences in paraurethral tissue stiffness between these groups. Given the established role of tissue elasticity in the pathophysiology of SUI, SE will be investigated as a potential diagnostic tool in urogynecological evaluations.

This prospective cohort study will be conducted at a tertiary referral center. All participants will undergo introital two-dimensional (2D) ultrasound in the midsagittal plane at rest. SE will be performed in three predefined suburethral regions of interest (ROIs):

  • internal urethral orifice (IUO) level
  • midurethra (MU) level
  • external urethral orifice (EUO) level

The adipose layer (AL) between the external urethral meatus and the pubic symphysis will serve as the reference tissue, representing the softest anatomical structure in the region.

Descriptive and comparative statistical analyses will be conducted to assess differences in paraurethral tissue stiffness between the study groups.

It is hypothesized that SE will be able to detect differences in paraurethral tissue elasticity, with SUI being associated with increased tissue compliance. The study also aims to determine whether SE can reliably distinguish between varying degrees of tissue stiffness in women with SUI and continent controls.

Pathophysiological focus:

The study will explore key mechanisms underlying SUI, including:

  • Weakened bladder neck support
  • Impaired urethral stabilization due to increased tissue elasticity and collagen degradation
  • While conventional 2D ultrasound provides anatomical information, it does not directly evaluate tissue biomechanics. In contrast, SE enables real-time visualization of tissue elasticity, offering a promising adjunct to traditional urogynecological assessment methods.

Standardization and Protocol

The study will follow a standardized protocol to ensure reproducibility and high-quality data. Key methodological elements include:

  • Minimal probe compression during introital ultrasound to avoid artifacts
  • Bladder emptying prior to examination to eliminate confounding effects
  • Carefully standardized ROI placement across all patients
  • Controlled image acquisition conditions to reduce variability

Future Directions

  • Future research based on this study will aim to:
  • Optimize SE protocols and refine ROI placement strategies
  • Establish clinical cutoff values for differentiating tissue stiffness in SUI vs. continent women
  • Assess the long-term effects of pelvic floor muscle training (PFMT) and vaginal estrogen therapy on paraurethral biomechanics
  • Facilitate the integration of SE into routine urogynecological practice to support early diagnosis and personalized treatment strategies for SUI
02

Conditions studied

  • Urinary Incontinence
  • Urinary Incontinence, Stress
  • Urinary Incontinence (UI)
  • Urinary Bladder, Overactive
  • Incontinence, Overactive Bladder, Stress Urinary Incontinence
  • Stress Urinary Incontinence (SUI)

Keywords

  • Urinary Incontinence
  • Bladder dysfunction
  • Urine leakage
  • Stress urinary incontinence (SUI)
03

In context

Urinary Incontinence

1,363 studies on the registry are indexed under Urinary Incontinence; 228 are open to participants now.

This study's planned enrollment of 80 is below the median of 120 across 305 observational studies indexed under Urinary Incontinence.

Browse Urinary Incontinence studies →

Lead sponsor

Szeged University is the lead sponsor of 53 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study will include adult women in Hungary diagnosed with stress urinary incontinence (SUI), along with a control group of continent women. Participants will be recruited from urogynecology outpatient clinics, tertiary referral centers, and gynecology departments.

Inclusion criteria

  • Clinical diagnosis of stress urinary incontinence (SUI) based on patient history, physical examination, and/or urodynamic assessment.

Exclusion criteria

Exclusion Criteria:

  • Pelvic malignancy or history of pelvic radiation therapy
  • Urge urinary incontinence (UUI) or detrusor overactivity
  • Pelvic organ prolapse (POP) stage ≥ II (based on POP-Q classification)
  • Pregnancy or recent postpartum status (less than 6 months postpartum)
  • Neurological disorders affecting bladder function
  • Recurrent urinary tract infections (UTIs) or active lower urinary tract infection
  • Inability to undergo study procedures
  • Cognitive impairment or psychiatric conditions affecting informed consent or compliance
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Control group (asymptomatic women)

    This group consists of women without any symptoms of urinary incontinence. They serve as a baseline for comparison with the affected groups. No specific intervention is applied to this group.

    Diagnostic Test: Strain Elastography

  • Stress urinary incontinence (SUI) group

    This group includes women diagnosed with stress urinary incontinence (SUI), characterized by involuntary urine leakage during physical exertion, coughing, sneezing, or other activities that increase intra-abdominal pressure.

    Diagnostic Test: Strain Elastography

  • Stress urinary incontinence (SUI) with hypermobile urethra

    This subgroup includes women with stress urinary incontinence and hypermobility of the urethra, which is assessed through clinical examination and/or imaging techniques.

    Diagnostic Test: Strain Elastography

  • Stress urinary incontinence (SUI) without hypermobile urethra

    This subgroup consists of women with stress urinary incontinence but without significant urethral hypermobility. The absence of hypermobility may suggest intrinsic sphincter deficiency (ISD) as a primary factor in incontinence.

    Diagnostic Test: Strain Elastography

  • Stress urinary incontinence (SUI) group without estrogen therapy

    Women diagnosed with stress urinary incontinence (SUI) who do not receive vaginal estrogen therapy. This group will serve as a reference to assess the natural biomechanical properties of paraurethral tissues in SUI patients.

    Diagnostic Test: Strain Elastography

  • Stress urinary incontinence (SUI) group with estrogen therapy

    Women diagnosed with stress urinary incontinence (SUI) who undergo vaginal estrogen therapy as part of their treatment. This group will be evaluated to determine the effects of vaginal estrogen on paraurethral tissue elasticity and its potential role in improving urethral support and biomechanical properties.

    Diagnostic Test: Strain Elastography

Interventions

  • Diagnostic testStrain Elastography

    Strain elastography (SE) is a parametric imaging modality that assesses tissue deformation in response to externally applied pressure, providing qualitative and semi-quantitative information on tissue elasticity and mechanical properties. Unlike conventional 2D ultrasound, SE enables the objective evaluation of paraurethral tissue stiffness, which may play a role in the pathophysiology of stress urinary incontinence (SUI). SE will be performed on three predefined paraurethral regions to assess pelvic floor elasticity and biomechanical characteristics. A standardized protocol will be implemented to ensure high reproducibility, with controlled probe compression and precisely defined regions of interest. SE may improve the diagnostic accuracy and therapeutic decision-making for SUI by identifying differences in tissue compliance among affected women.

06

What researchers measure

Primary outcomes

  1. Assessment of Paraurethral Tissue Elasticity in Women with Stress Urinary Incontinence Using Strain Elastography

    Detection of a statistically significant difference in paraurethral tissue elasticity between women with stress urinary incontinence (SUI) and continent controls using strain elastography (SE), with high measurement reproducibility across predefined regions of interest.

    Time frame: At a single study visit, within two weeks of enrollment.

07

Study locations

1 of 1 sites recruiting
  • University of szeged
    Szeged, 6725, Hungary
    Recruiting
08

References and documents

Publications

  • Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas. 1996 Jul;24(3):197-204. doi: 10.1016/s0378-5122(96)82010-x. PubMed 8844634 ↗
  • Tunn R, Petri E. Introital and transvaginal ultrasound as the main tool in the assessment of urogenital and pelvic floor dysfunction: an imaging panel and practical approach. Ultrasound Obstet Gynecol. 2003 Aug;22(2):205-13. doi: 10.1002/uog.189. PubMed 12905521 ↗
  • DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol. 1994 Jun;170(6):1713-20; discussion 1720-3. doi: 10.1016/s0002-9378(94)70346-9. PubMed 8203431 ↗
  • Kreutzkamp JM, Schafer SD, Amler S, Strube F, Kiesel L, Schmitz R. Strain Elastography as a New Method for Assessing Pelvic Floor Biomechanics. Ultrasound Med Biol. 2017 Apr;43(4):868-872. doi: 10.1016/j.ultrasmedbio.2016.12.004. Epub 2017 Jan 17. PubMed 28108041 ↗
  • Zhao B, Wen L, Chen W, Qing Z, Liu D, Liu M. A Preliminary Study on Quantitative Quality Measurements of the Urethral Rhabdosphincter Muscle by Supersonic Shear Wave Imaging in Women With Stress Urinary Incontinence. J Ultrasound Med. 2020 Aug;39(8):1615-1621. doi: 10.1002/jum.15255. Epub 2020 Mar 3. PubMed 32125001 ↗
  • Falah-Hassani K, Reeves J, Shiri R, Hickling D, McLean L. The pathophysiology of stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2021 Mar;32(3):501-552. doi: 10.1007/s00192-020-04622-9. Epub 2021 Jan 8. PubMed 33416968 ↗
  • Patel UJ, Godecker AL, Giles DL, Brown HW. Updated Prevalence of Urinary Incontinence in Women: 2015-2018 National Population-Based Survey Data. Female Pelvic Med Reconstr Surg. 2022 Apr 1;28(4):181-187. doi: 10.1097/SPV.0000000000001127. Epub 2022 Jan 12. PubMed 35030139 ↗

Individual participant data

Plan to share: Yes — Quantitative strain elastography measurements of periurethral tissue elasticity.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06933407
Lead sponsor
Szeged University
Collaborators
Capio Specialized Center for Gynecology, Solna, 182 88 Stockholm, Sweden
Responsible party
Dr. Csákány Lóránt (Head of the Urogynecology Outpatient Clinic, Szeged University) — Principal investigator
First posted
Apr 18, 2025
Start date
Aug 16, 2024
Primary completion
Mar 30, 2025
Completion
Jan 1, 2030 (estimated)
Last update
Apr 18, 2025

Study contacts

Lóránt Csákány, Dr.
Contact
md.csakany@gmail.com
+36305895619

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion